Cargando…
HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway
High-mobility group AT-hook 2 (HMGA2), a member of the high mobility group family, has been reported to correlate with cancer progression. However, there is no report concerning the correlation between HMGA2 and metastasis in renal cell carcinoma. In the present study, we found that HMGA2 was highly...
Autores principales: | Kou, Bo, Liu, Wei, Tang, Xiaoshuang, Kou, Qingshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783590/ https://www.ncbi.nlm.nih.gov/pubmed/29138866 http://dx.doi.org/10.3892/or.2017.6091 |
Ejemplares similares
-
[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023) -
Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling
por: Lin, Yueh-Te, et al.
Publicado: (2020) -
Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
por: Thuault, Sylvie, et al.
Publicado: (2006) -
SUMOylation of Smad2 mediates TGF-β-regulated endothelial–mesenchymal transition
por: Su, Qi, et al.
Publicado: (2023) -
Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition
por: Sommerova, Lucia, et al.
Publicado: (2017)